Literature DB >> 12949970

Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waardenburg syndrome.

Bernd Wollnik1, Turgut Tukel, Oya Uyguner, Asadollah Ghanbari, Hulya Kayserili, Melike Emiroglu, Memnune Yuksel-Apak.   

Abstract

Type I Waardenburg syndrome (WS-I) is an auditory-pigmentary syndrome caused by heterozygous loss of function mutations in the PAX3 gene. Klein-Waardenburg syndrome (WS-III) is a very rare condition and represents an extreme presentation of WS-I, additionally associated with musculoskeletal abnormalities. We present an 18-months old Turkish child with typical Klein-Waardenburg syndrome (WS) including dystopia canthorum, partial albinism, and upper-limb defects. The child was born to a consanguineous couple and both parents had WS-I. We screened the entire coding region of the PAX3 gene for mutations and identified a novel missense mutation, Y90H, within the paired box domain of PAX3. Both parents were heterozygous for the mutation and the proposita was homozygous. This is the third report of a homozygous PAX3 mutation causing the WS-III phenotype. Molecular analysis of four additional Turkish families with variable clinical expression of WS-I identified two missense mutations, one splice-site mutation, and one small insertion in the PAX3 gene. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949970     DOI: 10.1002/ajmg.a.20260

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  16 in total

Review 1.  Signaling pathways and tissue interactions in neural plate border formation.

Authors:  Carolin Schille; Alexandra Schambony
Journal:  Neurogenesis (Austin)       Date:  2017-02-23

2.  Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II.

Authors:  Hua Zhang; Hongsheng Chen; Hunjin Luo; Jing An; Lin Sun; Lingyun Mei; Chufeng He; Lu Jiang; Wen Jiang; Kun Xia; Jia-Da Li; Yong Feng
Journal:  Hum Genet       Date:  2011-10-01       Impact factor: 4.132

3.  [Visual diagnosis: Waardenburg syndrome].

Authors:  T Hager; H-S Walter; B Seitz; B Käsmann-Kellner
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

4.  Insights into the Role of PAX-3 in the Development of Melanocytes and Melanoma.

Authors:  Jessica Diann Hathaway; Azizul Haque
Journal:  Open Cancer J       Date:  2011-01-01

5.  [Unilateral sensineural deafness associated with mutations in the PAX3-gene in Waardenburg syndrome type I].

Authors:  M Ptok; S Morlot
Journal:  HNO       Date:  2006-07       Impact factor: 1.284

Review 6.  Pigmentation PAX-ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease.

Authors:  Jennifer D Kubic; Kacey P Young; Rebecca S Plummer; Anton E Ludvik; Deborah Lang
Journal:  Pigment Cell Melanoma Res       Date:  2008-12       Impact factor: 4.693

7.  Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?

Authors:  Alona Gad; Mercy Laurino; Kenneth R Maravilla; Mark Matsushita; Wendy H Raskind
Journal:  Am J Med Genet A       Date:  2008-07-15       Impact factor: 2.802

Review 8.  Genetic insights, disease mechanisms, and biological therapeutics for Waardenburg syndrome.

Authors:  Sida Huang; Jian Song; Chufeng He; Xinzhang Cai; Kai Yuan; Lingyun Mei; Yong Feng
Journal:  Gene Ther       Date:  2021-02-25       Impact factor: 4.184

9.  A novel missense mutation of the paired box 3 gene in a Turkish family with Waardenburg syndrome type 1.

Authors:  Filiz Hazan; A Taylan Ozturk; Hamit Adibelli; Nurettin Unal; Ajlan Tukun
Journal:  Mol Vis       Date:  2013-01-29       Impact factor: 2.367

10.  Prenatal diagnosis and genetic counseling for Waardenburg syndrome type I and II in Chinese families.

Authors:  Li Wang; Litao Qin; Tao Li; Hongjian Liu; Lingcao Ma; Wan Li; Dong Wu; Hongdan Wang; Qiannan Guo; Liangjie Guo; Shixiu Liao
Journal:  Mol Med Rep       Date:  2017-10-25       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.